NANO MRNA Co.,Ltd.
4571.T
Price:
$140
Market Cap:
$9.91B
NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2008-03-05
Stock Exchange
JPX
Ticker
4571.T
PE Ratio
[-13.08]
ROE
[-27.51%]
Current Ratio
[4.10]
Dividend Yield
[0%]
Enterprise Value
[8.95B]
Dividend History
The ROE as of December 2025 (TTM) for NANO MRNA Co.,Ltd. (4571.T) is -27.51%
According to NANO MRNA Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -27.51%. This represents a change of 293.11% compared to the average of -7.00% of the last 4 quarters.
NANO MRNA Co.,Ltd. (4571.T) Historical ROE (quarterly & annually)
How has 4571.T ROE performed in the past?
The mean historical ROE of NANO MRNA Co.,Ltd. over the last ten years is -37.31%. The current -27.51% ROE has changed -26.27% with respect to the historical average. Over the past ten years (40 quarters), 4571.T's ROE was at its highest in in the December 2016 quarter at 0.14%. The ROE was at its lowest in in the December 2017 quarter at -47.56%.
Average
-37.31%
Median
-30.62%
Minimum
-116.20%
Maximum
-20.92%
NANO MRNA Co.,Ltd. (4571.T) ROE by Quarter and Year
Discovering the peaks and valleys of NANO MRNA Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.36%
Maximum Annual ROE = -20.92%
Minimum Annual Increase = -73.53%
Minimum Annual ROE = -116.20%
| Year | ROE | Change |
|---|---|---|
| 2025 | -30.49% | 33.74% |
| 2024 | -22.80% | -26.03% |
| 2023 | -30.82% | -8.82% |
| 2022 | -33.80% | -10.60% |
| 2021 | -37.81% | 64.98% |
| 2020 | -22.92% | -25.49% |
| 2019 | -30.76% | -73.53% |
| 2018 | -116.20% | 337.14% |
| 2017 | -26.58% | 27.07% |
| 2016 | -20.92% | 1.36% |
NANO MRNA Co.,Ltd. (4571.T) Average ROE
How has 4571.T ROE performed in the past?
The current ROE of NANO MRNA Co.,Ltd. (4571.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.04%
5-year avg
-31.14%
10-year avg
-37.31%
NANO MRNA Co.,Ltd. (4571.T) ROE vs. Peers
How is 4571.T’s ROE compared to its peers?
NANO MRNA Co.,Ltd.’s ROE is greater than MediciNova, Inc. (-23.12%), greater than Stella Pharma Corporation (-5.94%), greater than RaQualia Pharma Inc. (-12.38%), greater than MEDINET Co., Ltd. (-31.95%), less than Kidswell Bio Corporation (16.80%), greater than Chiome Bioscience Inc. (-56.15%), greater than Linical Co., Ltd. (-17.16%), less than CellSource Co., Ltd. (0.18%), greater than CellSeed Inc. (-60.98%), less than Satudora Holdings Co.,Ltd. (5.57%),
| Company | ROE | Market cap |
|---|---|---|
| -23.12% | $11.18B | |
| -5.94% | $7.59B | |
| -12.38% | $28.13B | |
| -31.95% | $7.41B | |
| 16.80% | $10.02B | |
| -56.15% | $7.28B | |
| -17.16% | $6.64B | |
| 0.18% | $7.83B | |
| -60.98% | $8.46B | |
| 5.57% | $11.01B |
Build a custom stock screener for NANO MRNA Co.,Ltd. (4571.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NANO MRNA Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
NANO MRNA Co.,Ltd. (4571.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like NANO MRNA Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is NANO MRNA Co.,Ltd.'s ROE?
How is the ROE calculated for NANO MRNA Co.,Ltd. (4571.T)?
What is the highest ROE for NANO MRNA Co.,Ltd. (4571.T)?
What is the 3-year average ROE for NANO MRNA Co.,Ltd. (4571.T)?
What is the 5-year average ROE for NANO MRNA Co.,Ltd. (4571.T)?
How does the current ROE for NANO MRNA Co.,Ltd. (4571.T) compare to its historical average?